Literature DB >> 28547591

MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project.

Mo Yang1, Harrison X Bai2, Li Yang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28547591     DOI： 10.1007/s11060-017-2500-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  3 in total

Review 1.  Prognostic role of microRNA-21 expression in gliomas: a meta-analysis.

Authors:  Chao Li; Jianjun Sun; Qian Xiang; Yan Liang; Nan Zhao; Zhuo Zhang; Qianxin Liu; Yimin Cui
Journal:  J Neurooncol       Date:  2016-08-16       Impact factor: 4.130

2.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

Authors:  Jennifer A Chan; Anna M Krichevsky; Kenneth S Kosik
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

3.  MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).

Authors:  Chuan He Yang; Junming Yue; Susan R Pfeffer; Meiyun Fan; Elena Paulus; Amira Hosni-Ahmed; Michelle Sims; Sohail Qayyum; Andrew M Davidoff; Charles R Handorf; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157
  3 in total
  2 in total

1.  Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma.

Authors:  Chen Jin; Jie Zhao; Zhi-Ping Zhang; Ming Wu; Jian Li; Ge-Lei Xiao; Bo Liu; Yu-Xiang Liao; Jing-Ping Liu
Journal:  J Neurooncol       Date:  2020-05-29       Impact factor: 4.130

2.  Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma.

Authors:  Haiwei Wang; Xinrui Wang; Liangpu Xu; Ji Zhang; Hua Cao
Journal:  Front Oncol       Date:  2021-04-20       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.